Novo Nordisk | NVO - Aset Lancar





Aset Lancar Perubahan Tanggal
ANI Pharmaceuticals USD 747.08M 6.03M 2026-03
Aurora Cannabis CAD 445.84M 22M 2025-12
Bausch Health Companies USD 5.98B 179M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Canopy Growth CAD 524.67M 78.85M 2025-12
Corcept Therapeutics USD 426.03M 59.43M 2026-03
Drreddys Laboratories INR 3.31B 164.26M 2025-12
Eli Lilly USD 54.84B 794M 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
Merck USD 35.02B 8.5B 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Novartis USD 26.61B 3.85B 2026-03
Novo Nordisk DKK 177.32B 4.86B 2026-03
Novo Nordisk DKK 25.71B 148.69B 2025-06
Pacira USD 514.96M 33.01M 2026-03
Perrigo USD 2.71B 85M 2026-03
Phibro Animal Health USD 894.07M 31.88M 2026-03
Prestige Brands USD 433.43M 63.98M 2025-12
Sanofi EUR 30.16B 789M 2026-03
Supernus Pharmaceuticals USD 731.58M 87.4M 2026-03
Zoetis USD 6.47B 294M 2026-03